We have isolated and identified the biotype of environmental mycobacteria from the expectorate of leprosy patients, their contacts, their drinking water supply and also from the sputa samples of tuberculosis paUents. 78% of the isolates from lepromatous leprosy patients and their contacts were Mycobacterium fortuitum-chelonae complex (MFC), 9% Mycobacterium avium complex (MAC), 9% Mycobacterium scrofulaceum and 4=/o were Mycobactenum smegmatis. Among the isolates from tuberculosis patients 63% belonged to M. fortuitum-chelonae complex, 19% to M. avium complex, 12% to Mycobacterium Kansasliand 6% to M. smegmatis. NI the isolates were multi-drug resistant when tested for sensitivity total of 21 drugs. The Mycobacterium fortuitum.chelonae complex organisms from leprosy contacts were more sensitive to rffampicin than those isolated from lepromatous leprosy and tuberculosis patients. Among 23 Isolates from leprosy patients one isolate was resistant to 20 drugs, one isolate to 17 drugs and another isolate was resistant to 13 drugs. Among the 18 isolates from drinking water supply six showed resistance to more than 12 drugs. Polymerase Chain Reaction (PCR) and subsequent hybridisation with specific probes confirmed all the isolated strains as nontuberculous mycobacteria (Using genus primers and probe sensitivity 100%) and none as M. tuberculosis, suggesting that PCR could be used to rapidly identify mycobacteria at the genus level and to rule out tuberculosis in leprosy patients at an early stage to decide on appropriate course of therapy.
INTRODUCTION
Several saprophytic and environmental mycobacteria have been found to be associated with human diseases either as potential pathogens or as causative organisms (1) . Included in this list are Mycobacterium fortuitum-chelonae complex, M. scrofulaceum, M. kansasii, M. xenopi which were once believed to be only environmental. They appear not to be present in the commensal flora of most individuals. Exposure of an individual to mycobacteria is variable and it is greatly influenced by the environment (for example soil and water) and the life style of the individual. The relevance of environmental mycobacteria in human health and diseases lies in the fact that clinically it is difficult to differentiate any one of them as specific etiological agent of pulmonary disease (1-2) and many of these mycobacteria have a positive immunomodulatory role in man (3) .
It has been shown at least in experimental animals that infections with some non-tuberculous mycobacteria can offer same level of protection as BCG against tuberculosis (4) (5) (6) . Innate resistance to antibiotics has been reported in several of these environmental mycobacteria. Reports from many parts of the world have emphasised that the frequency of mycobacteria other than tuberculosis is increasing in both actual numbers and in the proportion of total mycobacterial disease (7) (8) (9) (10) (11) (12) (13) (14) (15) . Therefore, the environmental mycobacteria could significantly influence the control strategies of mycobacterial diseases like leprosy and tuberculosis particularly in the context of the global re-emergence of tuberculosis, emergence of mul@drug resistance in leprosy and tuberculosis and our lack of knowledge of the exact mechanism of pathogenesis and immune insufficiency in these two dreaded scourges of human health. The etx~cjical role, if any, played by these environmental mycobacteria in the disease process as opportunistic pathogens assume great signif~:ance for devising effective control The various anti-mycobacterial drugs used in this study are 4,4' diamino diphenyl sulphone, strategies. Considering the global re-emergence of tuberculosis, emergence of multi drug resistance in leprosy and tuberculosis, a detailed study of environemntai mycobacteria acquires importance. The etiological role, if any, played by these environmental mycobacteria in the disease process as opportunistic paltKx:jen assumes great significance for devising effective control strategies.
In this context a detailed study of environmental mycobacteria, particularly from the inhabited area and drinking water supply, acquires importance. The present study aims at the isolation, polymerise chain reaction (PCR) based identification and characterisation of the biotype of environmental mycobacteda from expectorate of the leprosy patients, their contacts, drinking water supply and from the sputa of pulmonary tuberculosis patients. We have also studied the sensitivity pattem of the isolates to conventional and non-conventional antimycobacterial drugs.
MATERIALS AND METHODS
Expectorates of leprosy patients were collected from the in.patients of the hospital ~ in Chinglepet which is an endemic area for leprosy. Sixty-six sputum samples were collected of which 26 were from lepromatous leprosy (LL) patients and 40 from contacts of LL patients who ,showed no clinical and radiologkial evidence of pulmonary tuberculosis. 35 water samples collected from the Patients' water supply were also examined for the presence of environmental mycobacteda. 34 sputa samples were collected from patients diagnosed clinically to have tuberculosis. The method of Vestal (16) was followed for the isolation, identification and determination of drug sensitivity of the isolated strains. In the study we included as controls seven non-tuberculous mycobacteria maintained in the laboratory. The percentage resistance of an isolate to a particular drug was calculated as follows:
Colonies on drug plate Colonies on control plate X100 = %resistance clofazimine, rifampicin, isonicotinic acid hydrazide, pyrazinamide, ethambutal and streptomycin. We have also tested other non-conventional drugs as antimycobacterials, such as gentamycin, tetracycline, kanamycin, chloramphenicol, ethionamide, methogyl, furoxone, nalidixic acid, para amino salicylate AS, ciprofloxacin, trimethoprim, doxycycline, amoxycilin and perfioxin (Table 1 ) . 
Sample processing for PCR
The samples were processed for PCR as described earlier (17) . The samples were washed twice with the TEX (Tris.Cl buffer 10 mM, pH 80; EDTA 5mM; Triton-X 100) buffer and the washed pellets were boiled for30 min in a final volume of 100 td of TEX to release the DNA for PCR.
PCR amplification
The p r~ samples (34 HI) were amplified in 50 ĩ1 reaction volume containing 1U Taq DNA polymerasa (Perkin-Elmer Cetus), 70 mM Tris pH 8. (2'-spiroadamantane)-4-methoxy-4-(3"phosphory-loxy)-phenyl-l,2-dioxentane-(Tropix Inc, Bedford, MA) for the detection by exposing filters to X-ray film (Hyperfilm TM, Amersham) for40 min at room temperature.
RESULTS
Environmental mycobactena were isolated from the expectorate from 9 out of 26 LL patients, 14 out of 40 contacts of leprosy patients and 18 out of 35 water samples. Several isolates belonged to M.fortuitumchelonei complex. All ~e drinking water supply isolates belonged to M.fortuiturn-chelonei (MFC) complex. All the isolates of mycobactena from the leprosy paints and their biochemical charactedsation showed 67% of isolates from LL patients, 79% of isolates from leprosy contacts and 100% of isolates from contacts belonged to MFC complex. The isolates were subsequen~ tested by genus specific pdmers and probe (Fig 1) .
ofPCR produc=
Products from PCR amplification were analysed b' . agarose gel elecb'ophoresis, "Southem Blot" and" Dc Bloc hyt~idisardon. For Southern analysis 15~1 of the PCF product were resolved on 12% agarose gel an( transferred onto hybridisation membrane (Magna NT TM Micron Separations, Inc., MSI, Westtx)ro, MA, USA) ar~ for dot blot analysis.15 I~1 of the PCR product wen denatured with equal volume of 0.5 N NaOH, spotte~ ontD the hybridisatjon membrane using a vacuum filtratJc, minifold
Preparation of hybridilmtion probes
Cloned or amplified M.tuberculosis specJfic 383 bp (TB 400) DNA fragment (17) and Mycobacterium genus specific 310 bp (18) DNA fragment were used as probes.
The ~w e r e labcL.~l with dig-11-dUTP by PCR under conditions as described above except that dTrP was replaced by a mixture of digoxigenin 11-d UTP and dTFP (molar ratio 0.35 dUTP : 0.65 dTTP). Hybddisation was performed as described by Boehringer-Mannheim (Genius TM kit, Boehringer Mannheim, Indianapolis, IN). The coloufimetric substrate of Boehringer-Mannheim was subs0tuted bythe chemiluminescent subsb atu AMPPD,3- Fig. 1 . Analysis of genus PCR producL Agarose gel e l e c t r o --i s (upper rows) and Southern hybndisatx~ (bottom rows). The PCR product (310 bp) was resolved on 1.2% agarose gel and for visualisation it was stained with ethidium bromide (1 ig 100 m1-1) at room temperature for 1 hour and documented under UV illumination. Lane M = Marker DNA 4) X174 Hae III digest, lanes A-D are amplicons from expectorates of leprosy patients, lanes E4 are amplicons from sputa of TB patients and lane J = negatNe control.
NoneofthembelongedtoM.tubercu/osLs, as determined The sensitMty of all these iso~at~s was tested against after PCR amplification and hybridisation to 21 drugs. AII the isolates and the control organisms M tuberculosis specific probe TB400 (data not shown), were multi drug resistant. The resistance among the MFC isolates of the LL patients (Table 2) varied from 75% to 100% for dapsone and 80% to 100% for clofazimine and 75% to 100% for rifampicin. This is compared to 30%, 30% and 60% resistance of the control strains of M.fortuitum -che/onei for dapsone, clofazimine and rifampicin respectively. The isolates from the leprosy contacts were more sensitive (55%) to these drugs (Table 3 & Sensitivity was caleulated as described in the Methods. Names of the drugs are abreviated and for details please see Table I . All isolates are M. fortuitum -chelonae complex. compared to those from LL patients ( Table 2 & 5) . Among the 21 drugs tested, ethambutol, ciprofloxin and kanamycin were found to be active against the isolates from the LL patients at concentrations recommended by CDC (16) . Only ciprofloxin and kanamycin were found to be active against organisms isolated from water (Table. 6 ). Among isolates of MOTT from tuberculosis patients (Table  7) 63% belong to M. fortuitum-chelonae complex, 19% belong to M. avium complex, 12% belong to Mycobacterium kansasii and 6% belong to M. smegmatis. Two of the three M.avium complex isolates were sensitive to streptomycin and ethambutol. Complete resistance (100%) to INH was noticed in 5 of the 10 isolates of M.fortuitum, one each of the M.avium complex and M.kansasii. Four of the 10 isolates of M.fortuitum showed complete resistance to rifampicin the remaining isolates exhibiting more than 60% resistance to these drugs. Many of them were sensitive to streptomycin, pyrazinamide and ethambutol (Table 7) . One of the M.avium complex isolates and one of the M.kansasii isolates showed total resistance to almost all the anti TB drugs. Rifampicin was found to be more active against MIortuitum-chelonei complex from leprosy contacts than from either LL or tuberculosis patients. Among the nonconventional antimycobacterial drugs tested, only kanamycin (5 l~g ml-~) and ciprofloxine (6 IJg m1-1) were found to be active against these isolates.
DISCUSSION
Frequency of isolation and tests for identifica.tion of non-tuberculous mycobacteria are important for clinicians, epidemiologists and for bacteriologists because patients suspected of having tuberculosis may excrete in the sputum not only tubercle bacilli but also other mycobacteria. These mycobacteria are non-pathogenic to guinea pigs and are (14) . It is not appreciated how common are the environmental mycobacteria in nature and how they could influence the health of human population (11) (12) (13) (14) .1n the present investigation we have evaluated the possibilities of using PCR to type the mycobacteria at the genus level and also to rule out Mycobacterium tuberculosis infection in the leprosy patients. All the isolates tested positive for Mycobacterium with the genus specific probe.
However, none of them tested positive for M. tuberculosis DNA. The usefulness of PCR for direct diagnosis of M. tuberculosis and other mycobacteria has already been established (16) . The PCR results correlate well with biochemical typing of the cultivated organisms. This suggests that PCR based diagnostics could be used to rapidly detect the mycobacteria at the genus level and only the positive samples need to be investigated further for M.tubercu/osis or other species identification in leprosy patients. The sensitivity and specificity of sample processing method and the PCR assay have already been validated for direct detection of Mycobacterium tuberculosis in sputa from patients (17) and therefore, instead of subjecting every sample to culture, this strategy could be applied particulady for the diagnosis of sub-clinical infection.
The negative predictive value of PCR being absolute under optimal conditions, PCR negative samples need not be subjected to culture isolation and analysis. This would also replace the AFB smear which has very limited sensitivity. Considering the sensitivity and specificity of PCR, if PCR is used unequivocal results of samples like, smear positive yet culture negative or smear negative (but clinically showing active disease) yet culture positive may become rare. This strategy would also bring down the cost of culturing by at least a third in endemic population like in India as only the genus PCR positive samples need to be cultured (if required). Further it will reduce the time taken to report the presence of mycobacteria or M.tubercu/osis in a given sample to two days instead of the conventional 4-6 weeks that is required for culture.Our current knowledge about the drug sensitivity pattern of the non-tuberculous mycobacteria is very limited and is particularly restricted to the conventional antituberculosis drugs. With some exceptions, nontuberculous mycobacteria are generally resistant to conventional anti-tuberculosis drugs by /n vitro standards. Of particular concern are diseases due to the M.avium complex and the M.fortuitum complex which present the most serious problems in chemotherapeutic management as nontuberculous mycobacterial isolates have been reported to be highly resistant to isoniazid, PAS and streptomycin (19) .
In the current study we investigated the sensitivity pattern of all the non-tuberculous mycobactenal isolates to 21 antibiotics The isolates from the leprosy patients, their contacts, the drinking water supply and those isolated from the tuberculosis patients sputa showed differences in sensitivity to these drugs. All the isolates were found to be multi-drug resistant and only the extent of resistance to various antibiotics was different. One isolate from water was found to be resistant to all the 21 drugs used in this study. Isolates from the contacts of the leprosy patients were more sensitive to rifampicin than those from leprosy patients probably because the leprosy contacts have not been exposed to rifampicin before. Further, rifampicin is being given to lepromatous leprosy patients at dosages much lower than that given for tuberculosis patients and this could also lead to selection of the resistant mutants of these fast-growers in the lepromatous leprosy patients. However, even among the ten M.fortuitum che/onae isolates from tuberculosis patients four were completely resistant to rifampicin which indicates that administration of lower dosage alone may not lead to selection of resistant mutants in leprosy patients. Additional mechanism could be operating in these organisms.
Plasmids have been identified in fast-growing mycobacteria particularly, M.fortuitum and M.che/onei, isolated from patients or from the environment (20) . The innate resistance in these mycobacteria isolated from sputum of leprosy patients or from their drinking water or sputa of TB patients could be either plasmid mediated or mediated through mobile genetic elements like insertion sequence(s)or transposons (21) . There has been no direct evidence to demonstrate that the observed drug resistance is conferred by plasmids or mobile genes nor has mobility of these mobile genetic elements from one mycobacteria to another been demonstrated. However, there could potentially be transfer of antibiotic resistance to the pathogenic mycobacteria from these non-pathogenic species. To understand the implications of the drug resistance of the MOTT organisms in the pathogenesis and the control of leprosy and tuberculosis, molecular mechanisms of resistance to these antibiotics and biochemical changes consequent to the development of resistance to these antibiotics need to be investigated.
